Skip to main content
Funded Studies

Holger Patzke, PhD

Principal Scientist at EnVivo Pharmaceuticals, Inc.

Location: Watertown, MA United States

Dr. Patzke has been working in the field of neuroscience since 1995. He holds a PhD from Goethe University in Frankfurt/Germany, where he investigated peripheral nervous system development at the Max-Planck-Institute for Brain Research. He then held a post-doctoral position at Harvard Medical School/HHMI in Boston, researching kinase signaling in mouse models of neurodegeneration and cortical development. 

Since 2004 he has held different positions at EnVivo Pharmaceuticals, a biotech company in Watertown, MA focused on discovering drugs for CNS disorders. At EnVivo Pharmaceuticals, he has led a project team that discovered novel histone deacetylase (HDAC) inhibitors for the treatment of neurodegenerative diseases, and identified a pre-clinical candidate compound. He has guided pre-clinical and clinical development in the HDAC program. 

Dr. Patzke has been awarded several personal research grants, has published original research papers and reviews in peer-reviewed journals and is inventor on patents.

Associated Grants

  • Potential Efficacy of a Novel HDAC Inhibitor in Pre-clinical Models of Parkinson's Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.